首页> 外文会议>National Biomedical Engineering Meeting >Determination of Diffusion Weighted Magnetic Resonance Imaging Based Biomarkers of Mild Cognitive Impairment in Parkinson’s Disease
【24h】

Determination of Diffusion Weighted Magnetic Resonance Imaging Based Biomarkers of Mild Cognitive Impairment in Parkinson’s Disease

机译:基于帕金森病的轻度认知障碍的扩散加权磁共振成像的测定

获取原文

摘要

This study aims to specify biomarkers of Parkinson's disease mild cognitive impairment (PD-MCI) based on fractional anisotropy (FA) and mean diffusivity (MD) maps obtained from diffusion weighted magnetic resonance imaging (DWMRI). T1 and diffusion weighted MR images collected from 27 cognitively normal Parkinson's disease (PD-CN), 32 mild cognitively impaired Parkinson's disease (PD-MCI), and 18 healthy control (HC) volunteers, at a clinical 3T MR scanner, were processed using FMRIB Software Library (FSL)'s toolboxes. Average regional values of FA and MD maps and tract based spatial statistics (TBSS) were utilized to define statistically significant differences between the participant subject groups.
机译:本研究旨在基于从扩散加权磁共振成像(DWMRI)获得的分数各向异性(FA)和平均扩散率(MD)地图来指定Parkinson疾病轻度认知障碍(PD-MCI)的生物标志物。从27例认知正常的帕金森病(PD-CN)中收集的T1和扩散加权MR图像,使用FMRIB软件库(FSL)的工具箱。 FA和MD地图和基于机构的空间统计(TBS)的平均区域值被利用来定义参与者主题组之间的统计上显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号